Trending...
- Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community
- International Rights Groups Raise Alarm Over Freedom of Religion and Expression in South Korea
- The City's Most Elegant Open-Air Dinner Party Returns September 12, 2026
FAYETTEVILLE, Ark. - WisconsinEagle -- Lineus Medical is pleased to announce a new distribution agreement with DIMA MedTech, marking the company's entry into the Italian market and further expanding its growing presence across Europe after receiving CE mark in December of 2025. Through this agreement, DIMA MedTech will provide Lineus Medical with a local presence in Italy as well as support the introduction and expansion of SafeBreak Vascular throughout Italy.
SafeBreak Vascular is the only breakaway device for IV lines clinically proven to reduce multiple IV complications.1 When a harmful force is placed on an IV line, SafeBreak intentionally separates to remove the damaging force from the IV line and protect the patient's vascular access. Upon separation, valves on both ends of the device close, preventing medicine spills from the pump and blood loss from the patient. The separated device causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile device is installed, and the patient's infusion is continued. SafeBreak Vascular is cleared for all vascular lines down to two weeks of age– delivering better outcomes for patients, efficiency for nurses, and cost savings for hospitals alike.1
More on Wisconsin Eagle
Larry Hayes, Lineus Medical's Chief Commercial Officer, stated, "This agreement marks another significant milestone in Lineus Medical's international growth. By partnering with DIMA MedTech, we are beginning our commercialization strategy in Europe and continuing to build momentum for broader global adoption. DIMA MedTech's local expertise and established network make them the right partner to drive commercial success throughout Italy."
Vance Clement, CEO of Lineus Medical, stated, "Expanding into Italy is a meaningful step forward in our mission to remove the "pains" associated with medical lines. First came European regulatory clearance for our product, and next is the establishment of a robust European distribution network. DIMA MedTech is a terrific distributor in Italy and our first in Europe."
About Lineus Medical
Lineus Medical develops innovative medical technologies designed to improve patient safety and healthcare efficiency. Its flagship product, SafeBreak Vascular, is a breakaway device for IV lines that helps protect patients from accidental IV dislodgements and associated complications.1
More on Wisconsin Eagle
About DIMA MedTech
DIMA MedTech is an operational partner for international medical technology companies seeking to establish and grow their presence in Italy. The company provides regulatory support, nationwide distribution, technical assistance, and local market expertise through a flexible operational model designed to simplify healthcare market entry and expansion.
References:
SafeBreak Vascular is the only breakaway device for IV lines clinically proven to reduce multiple IV complications.1 When a harmful force is placed on an IV line, SafeBreak intentionally separates to remove the damaging force from the IV line and protect the patient's vascular access. Upon separation, valves on both ends of the device close, preventing medicine spills from the pump and blood loss from the patient. The separated device causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile device is installed, and the patient's infusion is continued. SafeBreak Vascular is cleared for all vascular lines down to two weeks of age– delivering better outcomes for patients, efficiency for nurses, and cost savings for hospitals alike.1
More on Wisconsin Eagle
- New Research Finds a Good Deal Is All It Takes to Get Americans Booking a Last-Minute Vacation — and Most Already Have One on Their Mind
- GitKraken Introduces GitLens 19, Bringing Human and AI Workflows Together in One Workbench
- LĪNA Universal Balm Nominated for "Best Clean Skincare Product" at CertClean Beauty Awards
- Bronze Stevie Award Recognizes Satyadhar Joshi for AI Research and Public Policy Engagement
- synseer Nominated for Best Startup in 2026 Prix Galien USA Awards Following Record Breaking Applicant Pool
Larry Hayes, Lineus Medical's Chief Commercial Officer, stated, "This agreement marks another significant milestone in Lineus Medical's international growth. By partnering with DIMA MedTech, we are beginning our commercialization strategy in Europe and continuing to build momentum for broader global adoption. DIMA MedTech's local expertise and established network make them the right partner to drive commercial success throughout Italy."
Vance Clement, CEO of Lineus Medical, stated, "Expanding into Italy is a meaningful step forward in our mission to remove the "pains" associated with medical lines. First came European regulatory clearance for our product, and next is the establishment of a robust European distribution network. DIMA MedTech is a terrific distributor in Italy and our first in Europe."
About Lineus Medical
Lineus Medical develops innovative medical technologies designed to improve patient safety and healthcare efficiency. Its flagship product, SafeBreak Vascular, is a breakaway device for IV lines that helps protect patients from accidental IV dislodgements and associated complications.1
More on Wisconsin Eagle
- Leading PDR Training Courses in Canada: Learn Paintless Dent Repair with PDR Academy & Tint Academy
- RIOUGA Launches the Try Becca Film Festival As Unique Film Event
- Move in this Fall! New Released Quick Move-In Townhomes at Heritage at South Brunswick with Limited-Time Incentives
- Crossroads4Hope Marks 25 Years Ensuring No One Faces Cancer Alone At its Inspiring Hope Gala
- Q1 2026 Arizona Technology Industry Impact Report Recaps Advanced Manufacturing Growth, High-Value Jobs and Workforce Investment
About DIMA MedTech
DIMA MedTech is an operational partner for international medical technology companies seeking to establish and grow their presence in Italy. The company provides regulatory support, nationwide distribution, technical assistance, and local market expertise through a flexible operational model designed to simplify healthcare market entry and expansion.
References:
- Data on File.
Source: Lineus Medical
0 Comments
Latest on Wisconsin Eagle
- Built to Last: Why BSI Is Among the Nation's Fastest-Growing Companies, and One of Its Best Places to Work
- Bent Danholm's The Architecture of Demand Reaches No. 2 in Amazon Real Estate Sales
- Contracting Resources Group Named to Inc. 5000 for the Ninth Time
- ImagineX Named to 2026 Inc. 5000 List of America's Fastest-Growing Private Companies
- ASSIST Software Becomes One of the First European Companies Certified to ISO/IEC 42001
- The World's No.1 Superstar® Enters the Occult with New Track and Cinematic Visual "Under Your Spell"
- PricZone Launches Online Shopping Platform Offering Electronics, Gaming, and More
- Colbert Packaging Sees Growth Opportunity in Secondary Packaging Inserts
- Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community
- Lineus Medical Elevates Leadership to Accelerate Growth After Breakthrough Clinical Results
- Gateway Center Arena Announces Duane Curry as General Manger
- Check out Chosen's Resource Fair and support foster and adoptive families!
- XRPPower Expands Platform Security With Enhanced Brand Protection and Official Verification Standards
- Cuvo Health, the #1 White Label Telehealth Platform, Surpasses 300 Exclusive Providers Serving All 50 States
- RAS AP Consulting Expands Managed AP Governance™ Ecosystem, Launches Trademark Process, and Secures IFOL Speaker Invitation
- UK Financial Ltd Makes History: Chainlink CRE Circulating Supply Verification Goes Live Across Its Complete Ecosystem Of Nine Exchange-Traded Tokens
- International Rights Groups Raise Alarm Over Freedom of Religion and Expression in South Korea
- The City's Most Elegant Open-Air Dinner Party Returns September 12, 2026
- FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)
- Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)


